Biological characterization of a β-galactosidase expressing clone of Trypanosoma cruzi CL strain

Memorias do Instituto Oswaldo Cruz

Volumn 97, Issue 8, 2002, Pages 1101-1105

  Le Senne, Ana ^a   Muelas Serrano, Susana ^a   Fernández Portillo, Carlos ^a   Escario, José Antonio ^a   Gomez Barrio, Alicia ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Biological characterization; Clone CL B5; Trypanosoma cruzi

Indexed keywords

ANTITRYPANOSOMAL AGENT; BENZNIDAZOLE; BETA GALACTOSIDASE; NIFURTIMOX; NITROIMIDAZOLE DERIVATIVE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CERCOPITHECUS; CLONING; DRUG EFFECT; DRUG SENSITIVITY; ENZYMOLOGY; GENETICS; MOUSE; TRYPANOSOMA CRUZI; VERO CELL;

ANIMALS; BETA-GALACTOSIDASE; CERCOPITHECUS AETHIOPS; CLONING, ORGANISM; MICE; NIFURTIMOX; NITROIMIDAZOLES; PARASITIC SENSITIVITY TESTS; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI; VERO CELLS;

EID: 0036979685     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762002000800006     Document Type: Article

References (28)

1. Andrade SG, Figeira RM, Carvalho ML, Gorini DF 1975. Influência da cepa do Trypanosoma cruzi na resposta à terapêutica experimental pelo Bay 2502. Rev Inst Med Trop São Paulo 17: 330-339.
2. Andrade SG, Magalhães JB, Pontes AL 1985. Evaluation of chemotherapy with benznidazole and mfurtimox in mice infected with Trypanosoma cruzi strains of different types. Bull WHO 63: 721-726.
3. Arévalo J, Panebra A, Santa Cruz C 1985. Relevance of hemin for in vitro differenciation of Trypanosoma cruzi. J Protozool 32: 553-555.
4. Barr SC, Rose D, Jaynes JM 1995. Activity of lytic peptides against intracellular Trypanosoma cruzi amastigotes in vitro and parasitemia in mice. J Parasitol 81: 974-978.
5. Braga MS, Lauria-Pires L, Argañaraz ER, Nascimento RJ, Teixeira RL 2000. Persistent infections in chronic Chagas' disease patients treated with anti-Trypanosoma cruzi nitroderivatives. Rev Inst Med Trop São Paulo 42: 157-161.
6. Brener Z, Costa CA, Chiari E 1976a. Differences in the susceptibility of Trypanosoma cruzi to active chemotherapeutic agents. Rev Inst Med Trop São Paulo 11: 245-249.
7. Brener Z, Golgher R, Bertelli MS, Texeira JA 1976b. Strain-dependent thermosensitivity influencing intracellular differentiation of Trypanosoma cruzi in cell culture. J Protozool 23: 147-150.
8. Buckner FS, Verlinde CLMJ, La Flamme AC, van Voorhis WC 1996. Efficient technique for screening drugs activity against Trypanosoma cruzi using parasites expressing β-galactosidase. Antimicrob Agents Chemother 40: 2592-2597.
9. Buckner FS, Griffin JH, Wilson AJ, van Voorhis WC 2001. Potent anti-Trypanosoma cruzi activities of oxidosqualene cyclase inhibitors. Antimicrob Agents Chemother 45: 1210-1215.
10. Castro JA, Díaz de Torranzo EG 1998. Toxic effects of nifurtimox and benznidazole, two drugs used against American tripanosomiasis (Chagas disease). Biomed Environ Sci 1: 19-33.
11. Croft SL, Urbina JA, Brun R 1997. Chemotherapy of human leishmaniasis and trypanosomiasis. In G Hide, JC Mottram, GH Coombs, PH Holmes (eds), Trypanosomiasis and Leishmaniasis Biology and Control, CAB International, Wallingford, Oxon, p. 245-257.
12. de Castro SL, Meirelles MN 1986. Effect of drugs on Trypanosoma cruzi and on its interaction with heart muscle cell in vitro. Mem Inst Oswaldo Cruz 82: 209-218.
13. Kirchhoff LV 1994. American trypanosomiasis (Chagas' disease) and African trypanosomiasis (sleeping sickness). Curr Op Infect Dis 7: 542-546.
14. Martínez-Díaz RA, Escario JA, Nogal Ruiz JJ, Gómez-Barrio A 2000. Evaluation of drug activity against intracellular forms of Trypanosoma cruzi employing enzyme immunoassay. J Clin Pharm Ther 25: 43-47.
15. Martínez-Díaz RA, Escario JA, Nogal Ruiz JJ, Gómez-Barrio A 2001. Biological characterization of Trypanosoma cruzi strains. Mem Inst Oswaldo Cruz 96: 53-59.
16. Melo RC, Brener Z 1978. Tissue tropism of different Trypanosoma cruzi strains. J Parasitol 64: 475-482.
17. Mendez S, Nell M, Fernández-Pérez FJ, Alunda JM 1999. Sensitivity of Leishmania infantum amastigotes to fluorinated L-ornithine analogues. Med Sci Res 27: 87-89.
18. Muelas S, Di Maio R, Cerecetto H, Seoane G, Ochoa C, Escario JA, Gómez-Barrio A 2001. New thiadiazine derivatives with activity against Trypanosoma cruzi amastigotes. Folia Parasitol 48: 105-108.
19. Muelas-Serrano S, Nogal JJ, Gómez-Barrio A 2000. Setting of a colorimetric method to determine the viability of Trypanosoma cruzi epimastigotes. Parasitol Res 86: 999-1002.
20. Muelas-Serrano S, Perez-Serrano J, Gómez-Barrio A, Ochoa C, Martinez J, Rodriguez-Caabeiro F 2001. In vitro effects of anti-Trypanosoma cruzi compounds on HSP60 levels. Parasitol Res 87: 615-618.
21. Neal RA, van Bueren J 1988. Comparative studies of drugs susceptibility of five strain of Trypanosoma cruzi in vivo an in vitro. Trans R Soc Trop Med Hyg 82: 709-714.
22. Osuna-Carrillo A, Jiménez-Ortiz A, Lozano-Maldonado J 1979. Medios de cultivo para la obtención de formas metacíclicas de Trypanosoma cruzi. Rev Ibér Parasitol 39: 129-133.
23. Rovai LE, Aoki A, Gerez de Burgos NM, Blanco A 1990. Effect of gossypol on trypomastigotes and amastigotes of Trypanosoma cruzi. J Protozool 37: 280-286.
24. Stoppani AOM 1999. Quimioterapia de la enfermedad de Chagas. Medicina 59: 147-165.
25. Werbovetz KA 2000. Target-based drug discovery for malaria, leishmaniasis, and trypanosomiasis. Curr Med Chem 7: 835-860.
26. Zingales B, Pereira MES, Almeida KA, Ulmezawa ES, Nehme NS, Oliveira RP, Macedo A, Souto RP 1997a. Biological parameters and molecular markers of clone CL Brener-The reference organism of the Trypanosoma cruzi genome project. Mem Inst Oswaldo Cruz 92: 811-814.
27. Zingales B, Pereira MES, Oliveira RP, Almeida KA, Ulmezawa ES, Souto RP, Vargas N, Cano MI, Franco da Silveira J, Nehme NS, Morel CM, Brener Z, Macedo A 1997b. Trypanosoma cruzi genome project: biological characteristics and molecular typing of clone CL Brener. Acta Trop 68: 159-173.
28. Zingales B, Rondinelti E, Degrave W, De Silveira JF, Levin M, Le Paslier D, Modabber F, Dobrokhotov B, Swindle J, Kelly JM, Aslund L, Hoheisel JD, Ruiz AM, Cazzulo JJ, Petterson U, Frasch AC (The Trypanosoma cruzi Genome Consortium) 1997c. The Trypanosoma cruzi genome initiative. Parasitol Today 13: 16-22.